Sort
82,697 grants matching “vaccine development”
Induction of protective t-cell responses to HIV-1
$686,250Andrew James McMichael · Duke University · UM1 · FY2012 · AI
Clinical Core
$686,229Raphael Dolin · Duke University · U19 · FY2010 · AI
Papillomavirus Virion Proteins and Vaccines
$686,183Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Fox COBRE Phase II Admin Core
$686,141Joseph M Fox · University Of Delaware · P20 · FY2020 · GM
Motivate, Vaccinate, Activateâ: An effectiveness-implementation trial to assess the impact of a multi-component community-based intervention to increase RSV vaccine uptake among Latino older adults
$686,134Carina Marquez · University Of California, San Francisco · R01 · FY2025 · MD
Motivate, Vaccinate, Activateâ: An effectiveness-implementation trial to assess the impact of a multi-component community-based intervention to increase RSV vaccine uptake among Latino older adults
$686,134Carina Marquez · University Of California, San Francisco · R01 · FY2024 · MD
HANTAVIRUS ECOLOGY AND DISEASE IN CHILE
$686,120University Of New Mexico · U19 · FY2003 · AI
Non-Human Primate Core (NHP Core)
$686,024Koen K Van Rompay · Duke University · P01 · FY2016 · AI
Miami Pediatric AIDS Clinical Trials Unit
$686,001University Of Miami School Of Medicine · U01 · FY2004 · AI
Evaluation of Memory Responses and Biomarkers from a Phase 1 Enterotoxigenic Escherichia coli (ETEC) Intramuscular Subunit Vaccine with dmLT Adjuvant
$685,989Elizabeth B Norton · Tulane University Of Louisiana · R56 · FY2021 · AI
Isolation of broadly protective monoclonal antibodies for Crimean Congo Hemorrhagic Fever
$685,980Mohammad Mohseni Sajadi · University Of Maryland Baltimore · R01 · FY2024 · AI
Discovery of long-acting, chemoprotective antimalarial compounds
$685,970Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2024 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$685,883Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Natural history, immunity, and transmission patterns of sapovirus in a Nicaraguan birth cohort
$685,837Sylvia Irene Becker-Dreps · Univ Of North Carolina Chapel Hill · R01 · FY2017 · AI
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
$685,832Sandra Aung · Ubivac, Llc · R44 · FY2010 · CA
IgM in the regulation of TB immunity
$685,810John R. Chan · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$685,757Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses
$685,700Donald L Sodora · Seattle Children'S Hospital · R01 · FY2018 · DE
Urban Water Systems, Enteric Pathogen Distribution & Gut Microbiome Development in Children: A Natural Experiment in Mozambique
$685,694Matthew C Freeman · Emory University · R01 · FY2022 · AI
Development and Testing of New Tuberculosis Vaccines
$685,682Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2007 · AI
The regulation and functions of Group 1 CD1-restricted T cells
$685,629Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2025 · AI
The regulation and functions of Group 1 CD1-restricted T cells
$685,629Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2024 · AI
Targeting natural killer cells to enhance HIV vaccine responses
$685,580Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · AI
Machine learning for identifying antigen-antibody interactions from massive sequencing data
$685,566Tao Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · AI
Malaria Vaccines: Pfs25-OMPC/MERCK ALUMINUM ADJUVANT
$685,543Yimin Wu · Niaid Extramural Activities · Z01 · FY2007 · AI